US stocks edge higher after 2 weeks of gains

NEW YORK — U.S. stocks edged higher in midday trading on Wall Street Monday following two weeks of gains.

Trading remained choppy as uncertainty continued over several ongoing trade disputes and their possible effect on economic growth.

Technology companies were among the early gainers. Qualcomm, Facebook and Netflix rose. Retailers also gained ground. Amazon and Hanesbrands climbed.

Utilities and makers of consumer products lagged the market as investors headed away from safe-play stocks to riskier holdings. Tyson Foods fell.

The muted gains mirror last week's pattern of choppy day-to-day trading as investors search for direction ahead of an interest rate decision by the Federal Reserve later this week.

KEEPING SCORE: The S&P 500 index rose 0.2% as of 11:55 a.m. Eastern time. The Dow Jones Industrial Average rose 45 points, or 0.2%, to 26,136. The Nasdaq composite rose 0.6%.

COSTLY PRESCRIPTION: Array BioPharma surged 55.1% after announcing that it had agreed to be bought by pharmaceutical giant Pfizer for $11.4 billion.

Array currently makes an advanced skin cancer treatment and has a deep pipeline of cancer drugs in development. Pfizer makes a wide range of cancer and other drugs. It is the biggest U.S. drugmaker by revenue.

SURGING BID: New York auction house Sotheby's surged 58.1% after announcing its sale to Patrick Drahi, a media and telecom entrepreneur and art collector.

MORE DEALS: Other companies were also moving after announcing deals. Oilfield services company C&J Energy Services surged 20% after announcing it is being bought by rival Keane Group in an all-stock deal. Legacy Texas Financial Group rose 3.9% after it announced a $2.1 billion cash and stock sale to regional bank Prosperity Bancshares.

MISALIGNED STOCK: Align Technology fell 6.9% after the medical device maker ended discussions about a potential distribution deal with Straumann Group.

The company focuses on products for the dental industry. The deal was initially part of a patent dispute settlement with a unit of Straumann. Instead, Align will receive a $16 million payment.

THE CONTEXT: The S&P 500 eked out a slight 0.5% gain last week. That followed a 4.4% weekly gain. Investors have been swinging between risky and safe-play holdings on a lack of developments in the ongoing trade war between the U.S. and China. Jitters over trade disputes and their impact on global economic growth have created a volatile market.

You may also interested in

Valeant, attempting to normalize operations, names new CFO

Aug 22, 2016

Valeant Pharmaceuticals is replacing Robert Rosiello as chief financial officer as the embattled pharmaceutical company attempts to normalize operations amid a host of ongoing investigations and class action suits

Several tornadoes likely hit Indiana, Ohio; no bad injuries

Aug 25, 2016

Authorities say a wave of severe storms likely produced several tornadoes in Indiana and Ohio, damaging homes and businesses but causing no serious injuries

Seattle weighs new rules for businesses with hourly workers

Aug 30, 2016

Seattle leaders have proposed new rules for retail and food-service businesses with hourly employees, including requiring them to schedule shifts two weeks in advance

People also read these

US stocks take small losses as energy companies slide

Aug 19, 2016

US stocks take small losses as the dollar regains a bit of strength and energy companies trade lower

Officials: Zika won't hurt South Florida tourism in long run

Aug 20, 2016

The discovery of Zika-carrying mosquitoes in South Florida certainly isn't ideal for tourism, but local officials and business leaders are confident the long-term impact on the tourism industry will be minor

Valeant, attempting to normalize operations, names new CFO

Aug 22, 2016

Valeant Pharmaceuticals is replacing Robert Rosiello as chief financial officer as the embattled pharmaceutical company attempts to normalize operations amid a host of ongoing investigations and class action suits

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!